{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:06:46Z","timestamp":1768313206353,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","award":["UL1 TR001439"],"award-info":[{"award-number":["UL1 TR001439"]}],"id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD052023"],"award-info":[{"award-number":["K12HD052023"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of Research on Women\u2019s Health (ORWH)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:13:55Z","timestamp":1559931235000},"page":"4040-4046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Regional variations in human papillomavirus prevalence across time in NHANES (2003\u20132014)"],"prefix":"10.1016","volume":"37","author":[{"given":"Jacqueline M.","family":"Hirth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Starkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabassum H.","family":"Laz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbey B.","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.001_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2019.06.001_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2019.06.001_b0015","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.lpm.2014.10.001","article-title":"HPV in genital cancers (at the exception of cervical cancer) and anal cancers","volume":"43","author":"de Sanjos\u00e9","year":"2014","journal-title":"La Presse M\u00e9dicale"},{"key":"10.1016\/j.vaccine.2019.06.001_b0020","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/21645515.2016.1141158","article-title":"Tempest in a teapot: a systematic review of HPV vaccination and risk compensation research","volume":"12","author":"Kasting","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.06.001_b0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/003335491613100313","article-title":"Human papillomavirus vaccination in Washington State: estimated coverage and missed opportunities, 2006\u20132013","volume":"131","author":"Oltean","year":"2016","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2019.06.001_b0030","doi-asserted-by":"crossref","first-page":"e009915","DOI":"10.1136\/bmjopen-2015-009915","article-title":"Continuing reductions in HPV 16\/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study","volume":"6","author":"Mesher","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2019.06.001_b0035","unstructured":"U.S. Food & Drug Administration, Gruber MF. December 10, 2014 Approval Letter - GARDASIL 9. https:\/\/www.fda.gov\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm426520.htm2014."},{"key":"10.1016\/j.vaccine.2019.06.001_b0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1158\/1055-9965.EPI-15-1294","article-title":"Missing the target for routine human papillomavirus vaccination: consistent and strong physician recommendations are lacking for 11- to 12-year-old males","volume":"25","author":"Vadaparampil","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.vaccine.2019.06.001_b0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MOP.0000000000000353","article-title":"Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance","volume":"28","author":"Bratic","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2019.06.001_b0050","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1586\/14760584.2015.1078240","article-title":"An update on barriers to adolescent human papillomavirus vaccination in the USA","volume":"14","author":"Berenson","year":"2015","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.06.001_b0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0060","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.vaccine.2014.02.097","article-title":"Geographic variation in human papillomavirus vaccination uptake among 13\u201317 year old adolescent girls in the United States","volume":"32","author":"Rahman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.001_b0065","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4161\/21645515.2014.980202","article-title":"Regional variations in HPV vaccination among 9\u201317 year old adolescent females from the BRFSS, 2008\u20132010","volume":"10","author":"Hirth","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.06.001_b0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10900-015-9995-2","article-title":"Differences in HPV immunization levels among young adults in various regions of the United States","volume":"40","author":"Rahman","year":"2015","journal-title":"J Commun Health"},{"key":"10.1016\/j.vaccine.2019.06.001_b0075","unstructured":"Centers for Disease Control and Prevention. Cervical cancer rates by state. In: Centers for Disease Control and Prevention, editor. Cancer prevention and control 2013."},{"key":"10.1016\/j.vaccine.2019.06.001_b0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.001_b0085","unstructured":"National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey: Questionnaires, datasets, and related documentation."},{"key":"10.1016\/j.vaccine.2019.06.001_b0090","unstructured":"Advisory Committee on Immunization Practices, Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, et al. Quadrivalent human papillomavirus vaccine: Recommendations of teh Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56:1-24."},{"key":"10.1016\/j.vaccine.2019.06.001_b0095","unstructured":"United States Census Bureau. Census divisions and Census regions."},{"key":"10.1016\/j.vaccine.2019.06.001_b0100","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/infdis\/jiw515","article-title":"Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009\u20132012","volume":"214","author":"Berenson","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National health and nutrition examination surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.AOG.0000254165.92653.e8","article-title":"Cervical cancer incidence in a prevaccine era in the United States, 1998\u20132002","volume":"109","author":"Saraiya","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.06.001_b0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.06.001_b0120","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2019.06.001_b0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.vaccine.2019.06.001_b0130","unstructured":"U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2013 incidence and mortality web-based report. In: U.S. Department of Health and Human Services, editor. Atlanta: Centers for Disease Control and Prevention, National Cancer Institute; 2016."},{"key":"10.1016\/j.vaccine.2019.06.001_b0135","unstructured":"Bureau USC. 2011-2015 American Community Survey 5-year estimates. American Fact Finder: U.S. Census Bureau."},{"key":"10.1016\/j.vaccine.2019.06.001_b0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/jiu394","article-title":"Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age","volume":"211","author":"Banister","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0145","unstructured":"Institute NC. SEER Stat Fact Sheets: Cervix uteri cancer. 2015."},{"key":"10.1016\/j.vaccine.2019.06.001_b0150","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1016\/j.vaccine.2016.07.014","article-title":"Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National immunization survey-teen (2008\u20132013)","volume":"34","author":"Hirth","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.001_b0155","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2018.03.083","article-title":"Human papillomavirus vaccination coverage among females and males, National health and nutrition examination survey, United States, 2007\u20132016","volume":"36","author":"Lewis","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.06.001_b0160","doi-asserted-by":"crossref","unstructured":"The FUTURE II Study Group. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. New England Journal of Medicine. 2007;356:1915-27.","DOI":"10.1056\/NEJMoa061741"},{"key":"10.1016\/j.vaccine.2019.06.001_b0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clinthera.2013.11.003","article-title":"Update on vaccination clinical trials for HPV-related disease","volume":"36","author":"Erickson","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2019.06.001_b0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinthera.2013.12.005","article-title":"The Australian experience with the human papillomavirus vaccine","volume":"36","author":"Garland","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2019.06.001_b0175","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.001_b0180","first-page":"850","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years - United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2019.06.001_b0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/AOG.0000000000002193","article-title":"Change in human papillomavirus prevalence among U.S. women aged 18\u201359 years, 2009\u20132014","volume":"130","author":"Berenson","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.06.001_b0190","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction\u2014National health and nutrition examination survey, United States, 2003\u20132014","volume":"216","author":"Oliver","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0195","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/infdis\/jix299","article-title":"Different challenges in eliminating HPV16 compared to other types: a modeling study","volume":"216","author":"Baussano","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.001_b0200","first-page":"363","article-title":"Human papillomavirus vaccination and age at first sexual activity","volume":"56","author":"Petrosky","year":"2017","journal-title":"Nat Health Nutri Exam Surv"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:54Z","timestamp":1759401234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":40,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19307509"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional variations in human papillomavirus prevalence across time in NHANES (2003\u20132014)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}